AUTONOMIX MEDICAL INC

AMIXNASDAQ

🏆 #3858 by market capEarnings Aug 12US Equity

$9.12▼ $0.17 (−1.83%)

🌙 After hours$9.00▼ 1.34%Regular close · extended-hours price shown

1h—

24h▼ 1.8%

7d—

14d—

30d—

1y—

🏦Market Cap

$9M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

—

Otter Score

Weak

No chart data available for AMIX.

Trading Snapshot

Day Range: $9.01 – $9.28
52-Week Range: $2.44 – $32.55
Volume: $1.92B
Avg Volume: $1.98B
Shares Outstanding: 970,000
Next Earnings: Oct 22, 2026

Fundamentals Snapshot

Annual Revenue: $574,442
Last Q Revenue: $152,000
P/E Ratio: —
P/S Ratio: —
EPS (TTM): $-3.05
Dividend Yield: —

Why Investors Own AMIX

✓High-growth profile — revenue up +35.1% YoY with expanding US Equity exposure.
✓Healthy economics — 39% gross margin and 29% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$574,442▲ +31.6% YoY

Gross Margin (TTM)

38.5%▲ +0.0% YoY

Operating Income (TTM)

$145,334▲ +31.6% YoY

Free Cash Flow (TTM)

$166,014▲ +31.6% YoY

About AUTONOMIX MEDICAL INC

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

🦦